SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER OUS is a 100-patient prospective, non-randomized, multicenter trial designed to assess the safety and efficacy of the Temporary Spur Stent System compared to […]
Other News
Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares
BEDMINSTER, N.J., and DUBLIN, Ireland, July 29, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares (“ADSs”), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of […]
Silk Road Medical Reports Second Quarter 2019 Financial Results and Raises 2019 Outlook
SUNNYVALE, Calif., July 29, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2019. Recent Highlights Revenue of $14.9 million for the second quarter of […]
Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States
REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that physicians in four U.S. sites have successfully treated several patients with […]
Magenta Medical Closes Funding Round Led by NEA in Its First-Ever Life Sciences Investment in Israel
KADIMA, Israel, July 29, 2019 /PRNewswire/ — Magenta Medical, the developer of heart failure solutions based on proprietary miniaturized blood pump technology, today announced a financing round led by global venture capital firm New Enterprise Associates (NEA), with participation from existing investors, including Pitango Venture Capital, JVC Investment Partners and a group of private […]
Northeast Ohio Man Survives Extreme Cardiac Event, Receives 30+ Defibrillations
News Release Department of Marketing and Communications 11100 Euclid Avenue Cleveland, OH 44106 Northeast Ohio Man Survives Extreme Cardiac Event, Receives 30+ Defibrillations UH Geauga Medical Center team shows perseverance and expertise in incredible effort A Northeast Ohio man who experienced what likely would have been a deadly […]
Cardiovascular Systems, Inc. Announces Former U.S. Congressman Erik Paulsen Joins Board of Directors
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Erik Paulsen. He replaces director Scott Bartos, who is retiring from the board after […]
Merit Medical Reports Earnings For Second Quarter of 2019
Email Print Friendly Share July 25, 2019 16:01 ET | Source: Merit Medical Systems, Inc. Q2 2019 worldwide revenue of $255.5 million, up 13.7% as reported over Q2 2018 Q2 2019 core revenue on a comparable, constant currency basis* up 9.6% over Q2 2018 Q2 2019 GAAP EPS was $0.12, compared to $0.21 in Q2 […]
Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU
AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with conventional PCI for the treatment of anterior STEMI patients. The first patient enrolled into this study was treated at Oxford Heart Center, Oxford, […]
BioCardia Signs Exclusive Development Agreement With AstraZeneca
SAN CARLOS, Calif., July 25, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced it has signed an extension to a 2017 development agreement with AstraZeneca [NYSE:AZN] for BioCardia’s Helix™ biotherapeutic delivery catheter system. Under the terms of the initial pre-clinical […]



